Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

cDNA Sequence AF251705 (AF251705) Antikörper (PE)

Dieses Maus Monoklonal-Antikörper erkennt spezifisch in FACS. Er zeigt eine Reaktivität gegenüber Human.
Produktnummer ABIN2663841

Kurzübersicht für cDNA Sequence AF251705 (AF251705) Antikörper (PE) (ABIN2663841)

Target

cDNA Sequence AF251705 (AF251705)

Reaktivität

Human

Wirt

  • 1
Maus

Klonalität

  • 1
Monoklonal

Konjugat

  • 1
PE

Applikation

Flow Cytometry (FACS)

Klon

TX45
  • Aufreinigung

    The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions. The solution is free of unconjugated PE and unconjugated antibody.

    Isotyp

    IgG1 kappa
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Buffer

    Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide and 0.2 % (w/v) BSA .

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handhabung

    Protect from prolonged exposure to light. Do not freeze.

    Lagerung

    4 °C

    Informationen zur Lagerung

    The antibody solution should be stored undiluted between 2°C and 8°C.
  • Target

    cDNA Sequence AF251705 (AF251705)

    Andere Bezeichnung

    MAIR-II

    Hintergrund

    MAIR-II, myeloid-associated immunoglobulin-like receptor II, is the member 7 of Ig superfamily (IgSF7), also known as LMIR-II, CMRF-35 like molecule 4 (CLM-4), DIgR1, and CD300d. This transmembrane protein is expressed on monocytes/macrophages, granulocytes, mast cells, dendritic cells and some B cells. It is an activating immune receptor associated ITAM-bearing adapter DAP12 and FcRγ chain on macrophages. MAIR-II regulates myeloid cell activation and promotes secretion of cytokines and chemokines
Sie sind hier:
Chat with us!